Global immunoglobulin products market driven by the increase in the aging population

The global immunoglobulin products market has been forecast to increase at a compound annual growth rate (CAGR) of 10.3% through to 2015, driven by the increase in the aging population and the trend of an increase in mergers and acquisitions among the vendors.

Immunoglobulin A (IgA) is an antibody that plays a critical role in mucosal immunity. More IgA is produced in mucosal linings than all other types of antibody combined; between three and five grams are secreted into the intestinal lumen each day. This accumulates to 75% of the total immunoglobulin produced in the entire body.

The immunoglobulins market is a steadily growing market and it is expected to grow steadily in the forecast period without any significant thrust due to a weak pipeline with few innovations. The existing promising immunoglobulins are undergoing life-cycle management, with them being approved for new indications.

The expected growth in the overall market for immunoglobulins is due to reasons such as improved diagnosis of diseases and increasing number of patients as awareness about diseases increases; new indications where immunoglobulins are used; increased off-label uses; and the significantly high per-capita usage in the US.

The growth of the global immunoglobulin products market is proportional to the increase in the aging population. The immune system becomes weaker with age and the production of antibodies decreases. Thus, the continuous worldwide increase in the aging population is contributing to the increase in immune deficiency patients.

The increase in mergers and acquisitions is a key trend that is being witnessed by the global immunoglobulin products market. For instance, Baxter acquired Synovis Life Technologies Inc., a leading provider of biological and mechanical products for soft tissue repair, in February 2012.

This acquisition will expand the company's regenerative medicine and BioSurgery franchise used for soft tissue repair and microsurgery in a variety of surgical procedures.

Key players currently dominating the immunoglobulin products market include CSL Behring LLC, Baxter International Inc., Grifols S.A., and Octapharma AG.

For more information on the global immunoglobulin products market, see the latest research: Global Immunoglobulin Products Market

Follow us on Twitter @CandMResearch